CID 86278317

Pegdinetanib

Structural Information

Molecular Formula
C27H46N6O13S
SMILES
COCCNC(=O)OCC(COC(=O)NCCOC)OCCCC(=O)NCCNC(=O)CCN1C(=O)CC(C1=O)SC[C@@H](C(=O)O)N
InChI
InChI=1S/C27H46N6O13S/c1-42-12-8-31-26(40)45-15-18(16-46-27(41)32-9-13-43-2)44-11-3-4-21(34)29-6-7-30-22(35)5-10-33-23(36)14-20(24(33)37)47-17-19(28)25(38)39/h18-20H,3-17,28H2,1-2H3,(H,29,34)(H,30,35)(H,31,40)(H,32,41)(H,38,39)/t19-,20?/m0/s1
InChIKey
PQEJXGNZBLONLG-XJDOXCRVSA-N
Compound name
(2R)-2-amino-3-[1-[3-[2-[4-[1,3-bis(2-methoxyethylcarbamoyloxy)propan-2-yloxy]butanoylamino]ethylamino]-3-oxopropyl]-2,5-dioxopyrrolidin-3-yl]sulfanylpropanoic acid
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

11
References

234
Patents

694.28436 Da
Monoisotopic Mass

-5.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 695.29164 247.4
[M+Na]+ 717.27358 246.8
[M-H]- 693.27708 274.6
[M+NH4]+ 712.31818 272.8
[M+K]+ 733.24752 244.3
[M+H-H2O]+ 677.28162 230.1
[M+HCOO]- 739.28256 254.9
[M+CH3COO]- 753.29821 282.8
[M+Na-2H]- 715.25903 271.6
[M]+ 694.28381 266.2
[M]- 694.28491 266.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe